Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 6 | 2020 | 70 | 1.850 |
Why?
|
| NADPH Oxidases | 5 | 2020 | 109 | 1.490 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 11 | 2020 | 242 | 1.360 |
Why?
|
| Muscle, Skeletal | 14 | 2023 | 981 | 1.360 |
Why?
|
| Membrane Glycoproteins | 5 | 2017 | 405 | 1.220 |
Why?
|
| Reactive Oxygen Species | 13 | 2020 | 521 | 1.110 |
Why?
|
| NADPH Oxidase 2 | 7 | 2020 | 38 | 1.080 |
Why?
|
| Autophagy | 6 | 2018 | 417 | 0.950 |
Why?
|
| Calcium | 14 | 2020 | 1010 | 0.800 |
Why?
|
| Oxidative Stress | 10 | 2021 | 791 | 0.700 |
Why?
|
| Ankyrins | 1 | 2021 | 96 | 0.640 |
Why?
|
| Calmodulin | 7 | 2002 | 212 | 0.620 |
Why?
|
| Microtubules | 1 | 2018 | 133 | 0.510 |
Why?
|
| Diaphragm | 1 | 2018 | 101 | 0.500 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 195 | 0.430 |
Why?
|
| Muscular Dystrophy, Animal | 1 | 2014 | 10 | 0.430 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 280 | 0.420 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2017 | 128 | 0.410 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 429 | 0.400 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 65 | 0.400 |
Why?
|
| Alternative Splicing | 3 | 2023 | 307 | 0.390 |
Why?
|
| Computer Systems | 1 | 2013 | 35 | 0.390 |
Why?
|
| Mice, Inbred mdx | 5 | 2020 | 46 | 0.390 |
Why?
|
| Molecular Imaging | 1 | 2013 | 58 | 0.380 |
Why?
|
| Apoptosis | 4 | 2017 | 1827 | 0.370 |
Why?
|
| Genes, Reporter | 1 | 2013 | 341 | 0.360 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 358 | 0.360 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2016 | 99 | 0.360 |
Why?
|
| Animals | 31 | 2023 | 33912 | 0.350 |
Why?
|
| Mice | 20 | 2023 | 18301 | 0.350 |
Why?
|
| Cardiomegaly | 3 | 2021 | 117 | 0.330 |
Why?
|
| Glutaredoxins | 2 | 2021 | 31 | 0.310 |
Why?
|
| Oxidation-Reduction | 6 | 2021 | 436 | 0.310 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2018 | 179 | 0.300 |
Why?
|
| Heart | 3 | 2019 | 650 | 0.290 |
Why?
|
| Parkinson Disease | 1 | 2016 | 735 | 0.280 |
Why?
|
| Aging | 5 | 2019 | 1242 | 0.230 |
Why?
|
| Rotenone | 2 | 2016 | 12 | 0.220 |
Why?
|
| Myotonic Dystrophy | 2 | 2023 | 73 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 325 | 0.170 |
Why?
|
| Myocytes, Cardiac | 4 | 2021 | 668 | 0.170 |
Why?
|
| In Vitro Techniques | 3 | 2013 | 808 | 0.160 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4697 | 0.160 |
Why?
|
| NADPH Oxidase 4 | 1 | 2020 | 13 | 0.160 |
Why?
|
| Fatigue | 1 | 2021 | 191 | 0.160 |
Why?
|
| Cluster Analysis | 1 | 2021 | 414 | 0.160 |
Why?
|
| Signal Transduction | 6 | 2018 | 4686 | 0.150 |
Why?
|
| Cell Nucleus | 3 | 2017 | 556 | 0.150 |
Why?
|
| Peroxiredoxins | 1 | 2018 | 10 | 0.140 |
Why?
|
| Models, Biological | 3 | 2017 | 1371 | 0.140 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 3748 | 0.140 |
Why?
|
| Dystrophin | 1 | 2018 | 39 | 0.140 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2019 | 38 | 0.140 |
Why?
|
| Organogenesis | 1 | 2019 | 75 | 0.140 |
Why?
|
| Vasoconstriction | 1 | 2019 | 94 | 0.140 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 91 | 0.140 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 53 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2018 | 92 | 0.140 |
Why?
|
| Fluorescence | 2 | 2013 | 94 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2018 | 189 | 0.140 |
Why?
|
| Muscle Contraction | 1 | 2018 | 147 | 0.140 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 61 | 0.140 |
Why?
|
| Synapses | 1 | 2021 | 425 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2017 | 2406 | 0.130 |
Why?
|
| Myocardium | 3 | 2019 | 852 | 0.130 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 2326 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 480 | 0.130 |
Why?
|
| Mice, Knockout | 4 | 2023 | 3819 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 171 | 0.130 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 39 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 137 | 0.130 |
Why?
|
| Calcineurin | 1 | 2017 | 60 | 0.130 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2017 | 62 | 0.130 |
Why?
|
| Trehalose | 1 | 2017 | 21 | 0.130 |
Why?
|
| Heart Failure | 2 | 2021 | 2332 | 0.130 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 9 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 136 | 0.120 |
Why?
|
| Heart Ventricles | 2 | 2019 | 749 | 0.120 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2016 | 23 | 0.120 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 54 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2019 | 448 | 0.120 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 84 | 0.120 |
Why?
|
| Energy Metabolism | 1 | 2021 | 804 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 187 | 0.120 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 147 | 0.110 |
Why?
|
| Calcium Signaling | 4 | 2019 | 243 | 0.110 |
Why?
|
| Chromatin | 1 | 2019 | 499 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 157 | 0.110 |
Why?
|
| Glycolysis | 1 | 2016 | 174 | 0.110 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 434 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 197 | 0.110 |
Why?
|
| Endothelial Cells | 1 | 2018 | 523 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 619 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2000 | 718 | 0.110 |
Why?
|
| Rabbits | 5 | 2002 | 575 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 569 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 482 | 0.100 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2885 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 993 | 0.100 |
Why?
|
| Cytosol | 1 | 2013 | 135 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2013 | 79 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2013 | 67 | 0.100 |
Why?
|
| Cell Movement | 1 | 2016 | 876 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2013 | 234 | 0.090 |
Why?
|
| Biosensing Techniques | 1 | 2013 | 81 | 0.090 |
Why?
|
| Muscle Proteins | 3 | 2023 | 401 | 0.090 |
Why?
|
| Heat Stress Disorders | 1 | 2012 | 10 | 0.090 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2012 | 18 | 0.090 |
Why?
|
| Ribonucleotides | 1 | 2012 | 31 | 0.090 |
Why?
|
| Action Potentials | 3 | 2019 | 476 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 299 | 0.090 |
Why?
|
| Binding Sites | 4 | 2001 | 1133 | 0.090 |
Why?
|
| Hot Temperature | 1 | 2012 | 137 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1211 | 0.080 |
Why?
|
| Cell Survival | 1 | 2013 | 826 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2001 | 300 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 170 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1356 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1939 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2023 | 423 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1928 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2017 | 1571 | 0.070 |
Why?
|
| Male | 11 | 2021 | 64957 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 2395 | 0.070 |
Why?
|
| Calcium Channels, L-Type | 2 | 2016 | 50 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4738 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 3464 | 0.070 |
Why?
|
| Humans | 10 | 2018 | 131163 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum | 3 | 2017 | 149 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2019 | 594 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2019 | 2465 | 0.060 |
Why?
|
| Heart Rate | 2 | 2019 | 577 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2019 | 1021 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 6099 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 356 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6196 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2023 | 64 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 1801 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2023 | 235 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2021 | 74 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2001 | 687 | 0.040 |
Why?
|
| EF Hand Motifs | 1 | 2000 | 4 | 0.040 |
Why?
|
| Tryptophan | 1 | 2000 | 84 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 95 | 0.040 |
Why?
|
| Protein Binding | 2 | 2000 | 1652 | 0.040 |
Why?
|
| Kinetics | 1 | 2001 | 1088 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 268 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2000 | 200 | 0.040 |
Why?
|
| Diploidy | 1 | 2019 | 40 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2019 | 33 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2019 | 35 | 0.040 |
Why?
|
| Animal Feed | 1 | 2019 | 82 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2021 | 377 | 0.040 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 110 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 292 | 0.030 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 115 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 71 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 136 | 0.030 |
Why?
|
| Transgenes | 1 | 2019 | 316 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 38 | 0.030 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 83 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 53 | 0.030 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 263 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 227 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2019 | 349 | 0.030 |
Why?
|
| Morpholinos | 1 | 2016 | 9 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 106 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 173 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2016 | 32 | 0.030 |
Why?
|
| Malnutrition | 1 | 2019 | 163 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 46 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 45 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 407 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 86 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 58 | 0.030 |
Why?
|
| Proteolysis | 1 | 2017 | 200 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 172 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 348 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 378 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2016 | 279 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 468 | 0.030 |
Why?
|
| Protein Transport | 1 | 2016 | 366 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 686 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 1207 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 471 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 238 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1356 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 801 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 440 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 950 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 450 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 710 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 264 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2017 | 849 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2018 | 1345 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1149 | 0.020 |
Why?
|
| Reactive Nitrogen Species | 1 | 2012 | 8 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1121 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2012 | 45 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2002 | 79 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 254 | 0.020 |
Why?
|
| Mitochondria | 1 | 2017 | 785 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 265 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 576 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2426 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 4497 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 1979 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3763 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 3175 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 235 | 0.010 |
Why?
|
| Female | 2 | 2019 | 70963 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 241 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 623 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20987 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1999 | 7 | 0.010 |
Why?
|
| Apoproteins | 1 | 1999 | 11 | 0.010 |
Why?
|
| Cattle | 1 | 2000 | 501 | 0.010 |
Why?
|
| Trypsin | 1 | 1999 | 68 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 141 | 0.010 |
Why?
|
| Ryanodine | 1 | 1999 | 6 | 0.010 |
Why?
|
| Ethylmaleimide | 1 | 1999 | 6 | 0.010 |
Why?
|
| Diamide | 1 | 1999 | 3 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 1999 | 7 | 0.010 |
Why?
|
| Alkylation | 1 | 1999 | 10 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 716 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 787 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1999 | 47 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2000 | 1013 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26341 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 708 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1618 | 0.010 |
Why?
|